Tag: NTI drugs

Jan

8 Comments

Narrow Therapeutic Index Drugs: Stricter Bioequivalence Requirements Explained

Narrow therapeutic index drugs require stricter bioequivalence standards to ensure generic versions are as safe and effective as brand-name drugs. Learn how the FDA, EMA, and Health Canada regulate these critical medications.

Dec

15 Comments

Clinical Outcomes After NTI Generic Switches: What Studies Show

Studies show that switching to generic versions of narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and cyclosporine can lead to dangerous fluctuations in blood levels. Learn what the evidence says about clinical outcomes, risks, and how to protect yourself.